Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 22,162 shares at $97.12 ($2.2M) on 2014-12-15, disclosed to the SEC on 2014-12-16.
Scheduled sale ($2.2M) by VP, Finance and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.10 | 8,704 | $828K | 38.3% |
| 2 | $95.97 | 4,128 | $396K | 18.3% |
| 3 | $97.12 | 1,400 | $136K | 6.3% |
| 4 | $98.48 | 900 | $89K | 4.1% |
| 5 | $99.73 | 1,475 | $147K | 6.8% |
| 6 | $100.52 | 1,835 |
| $184K |
| 8.5% |
| 7 | $101.75 | 2,000 | $204K | 9.4% |
| 8 | $102.56 | 900 | $92K | 4.3% |
| 9 | $103.60 | 820 | $85K | 3.9% |
| Total | $97.50 avg | 22,162 | $2.2M | 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |